GHRP-6: research profile
Last updated Oct 8, 2026 · research counts checked Oct 7, 2026
Identity
- Name
- GHRP-6
- Also called
- growth hormone-releasing peptide 6; His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
- Sequence
- HWAWFK-NH₂ (6 residues)
- Molecular formula
- C46H56N12O6
- Molecular weight
- 873.0 g/mol
- Source
- PubChem CID 4345065 ↗
A synthetic hexapeptide with two D-amino acids and a C-terminal amide.
Sequences are shown only where the formula calculated from the sequence matches PubChem's formula exactly; CAS numbers only where the PubChem record lists a single valid one.
Published research record
Counts of database records matching the compound's names, as of Oct 7, 2026. They describe how much has been published and in what kind of study, not what any study found.
| Record type | Count | Source |
|---|---|---|
| PubMed records (any study type) | 673 | PubMed search ↗ |
| …indexed as animal studies, with no human tag | 371 | PubMed search ↗ |
| …indexed as clinical trials (in people) | 45 | PubMed search ↗ |
| …indexed as reviews | 29 | PubMed search ↗ |
| ClinicalTrials.gov registered studies | 0 | ClinicalTrials.gov search ↗ |
PubMed query: "GHRP-6"[tiab] OR "GHRP 6"[tiab] OR "growth hormone-releasing peptide-6"[tiab] OR "growth hormone releasing peptide 6"[tiab]. ClinicalTrials.gov query: "GHRP-6". PubMed's study-type tags are added by indexers and lag new records, and keyword matches can include records that only mention the compound, so read these as rough counts.
Regulatory status
- FDA (compounding): Listed in Category 2 under section 503B (added Sept 29, 2023). FDA source ↗
- Sport (WADA): WADA's Prohibited List names growth hormone-releasing peptides (GHRPs) such as GHRP-6 under S2. WADA Prohibited List ↗
- Research peptides from both vendors are sold for laboratory research use only, not for human or veterinary consumption. This summary isn't legal or regulatory advice.
Lab-tested GHRP-6 lots (2)
| Lot | Vendor · product | Report date | Lab | HPLC purity | Identity |
|---|---|---|---|---|---|
| GHRP6-5-001 | Peptira · GHRP-6 Vial 5 mg | Jan 11, 2026 | Freedom Diagnostics | 99.88% | Mass identified as GHRP-6 (LC-MS) |
| GH65N071425 | Paramount Peptides · GHRP-6 (5mg) | Jul 28, 2025 | Janoshik | 99.24% | Not reported |
Doses reported in published studies: GHRP-6: doses reported in published research (literature summary, not advice).
Organ systems in published research: Heart & blood vessels, Gut & digestive tract, Bone & cartilage, Pituitary & hormone axes.